0001181431-12-024660.txt : 20120418
0001181431-12-024660.hdr.sgml : 20120418
20120418205504
ACCESSION NUMBER: 0001181431-12-024660
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120410
FILED AS OF DATE: 20120418
DATE AS OF CHANGE: 20120418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zarrabian Saiid
CENTRAL INDEX KEY: 0001495521
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24274
FILM NUMBER: 12767083
MAIL ADDRESS:
STREET 1: P.O. BOX 675765
CITY: RANCHO SANTA FE
STATE: CA
ZIP: 92067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584526600
MAIL ADDRESS:
STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4/A
1
rrd342477.xml
FORM 4/A
X0305
4/A
2012-04-10
2012-04-12
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001495521
Zarrabian Saiid
4370 LA JOLLA VILLAGE DRIVE, SUITE 400
SAN DIEGO
CA
92122
1
0
0
0
Stock Option (Right to Buy)
0.06
2012-04-10
4
A
0
18907498
0
A
2022-04-10
Common Stock
18907498
18907498
D
This amendment is being filed solely to correct the number of derivative securities acquired and the number of derivative securities beneficially owned following the reported transaction, which were reported incorrectly in the original Form 4 due to an administrative error.
The option shall vest and become exercisable with respect to one-quarter of the underlying shares on each of April 20, 2012, July 20, 2012, October 20, 2012 and January 20, 2013.
By: /s/ Saiid Zarrabian
2012-04-18